Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He is also the author of the morning Pharmalittle newsletter ...
The FDA has approved Moderna’s influenza vaccine, the first licensed flu shot made using messenger RNA technology.
With a second delayed report of a child's death in China, criticism is rising of a looser form of clinical trial. One expert: ...
The FDA approved Replimune’s treatment for advanced melanoma, dealing the company and patient advocates a big win after a ...
AI is not the villain here; it is a mirror,” reflecting the diminishment of physician judgment, writes former surgeon Frances ...
To blame Fauci for not solving the origin of Covid-19 makes as much sense as blaming a detective in Washington, D.C., for not ...
Novo and Lilly earnings are out, Aurora Therapeutics slashing staff, and more biotech news from The Readout ...
A little-noticed government policy shift caused a seven-year delay in choosing a costly medicine for Medicare price ...
A Senate committee has voted to hold Anthony Fauci in contempt of Congress after he declined to answer questions about his ...
The leaders of the Federation of State Medical Boards weigh in on the question of licensing AI to practice medicine.
It was briefly more dangerous to sit at a desk in Atlanta than to chase a hemorrhagic fever in the field,” writes Daniel ...
Noel T. Brewer and colleagues will soon decide whether the U.S. has maintained its elimination status. Here’s what they’re ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results